CNR2 and amyotrophic lateral sclerosis: Although CB2 agonists (three relatively novel RO compounds, 10 mg/kg/day i.p. from ALS gene induction) suppressed microglial expansion and activation markers, this induced acute detrimental effects on levels of misfolded SOD1, whereas a CB2 inverse agonist had the opposite effect [303].